When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - FDA accepts Myovant application for relugolix for uterine fibroids
Myovant Sciences Ltd.
The FDA accepts for review Myovant Sciences' (NYSE:MYOV) marketing application seeking approval of relugolix combination tablet (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of women with heavy menstrual bleeding associated with uterine fibroids.
More news on: Myovant Sciences Ltd., Healthcare stocks news, Stocks on the move,